TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.62
+0.12 (2.18%)
Mar 28, 2025, 4:00 PM EDT - Market closed
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $175.79 million as of March 28, 2025. Its market cap has decreased by -28.25% in one year.
Market Cap
175.79M
Enterprise Value
190.89M
1-Year Change
-28.25%
Ranking
Category
Stock Price
$5.62
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $175.79M, a decrease of -46.53%. That is a compound annual growth rate of -14.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 175.79M | 15.07% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 744.72B |
| UnitedHealth Group | 474.76B |
| Johnson & Johnson | 395.70B |
| AbbVie | 359.17B |
| Novo Nordisk | 308.71B |
| Abbott Laboratories | 228.79B |
| Merck & Co. | 226.13B |
| AstraZeneca | 225.00B |